| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 01/25/2011 | US7875728 Hydrazonopyrazole derivatives and their use as therapeutics |
| 01/25/2011 | US7875724 intermediates for enantiomerically pure analogs having silyl or alkyl groups at C4 position; organometallic nucleophile or Grignard and an silyl or alkyl acyl halide reacted with nicotine; oxidation and deacylation to 4-hydroxy; modulate nicotinic acetylcholine receptors; Alzheimer's, Parkinson's |
| 01/25/2011 | US7875723 99.9% By weight of amorphous S-omeprazole magnesium, <0.1% by weight of impurities as determined by liquid chromatography; X-ray powder diffractogram; substantially free of neutral omeprazole; optical purity 94-96% e.e.; anhydrous; industrial scale; materials handling; filterable |
| 01/25/2011 | US7875644 1-acyldihydropyrazole derivatives |
| 01/25/2011 | US7875634 Cyano anthranilamide insecticides |
| 01/25/2011 | US7875633 Phenylpyridone derivative |
| 01/25/2011 | US7875631 e.g.1-(3,5-dichlorophenyl)-2-formyl-6-methoxy-1,2,3,4-tetrahydroisoquinoline; to prevent and/or treat cancer and other abnormal cell growth, and metabolic as well as blood vessel proliferate disorders, in which uncontrolled expression of insulin-like growth factor-1 receptor is observed |
| 01/25/2011 | US7875621 Substituted 2-alkyl quinazolinone derivatives as PARP inhibitors |
| 01/25/2011 | US7875619 Hetero substituted sodium channel blockers |
| 01/25/2011 | US7875615 Substituted triazole derivatives as oxytocin antagonists |
| 01/25/2011 | US7875608 Substituted 8-[6-amino-3pyridyl]xanthines |
| 01/25/2011 | US7875605 1-Benzenesulfonyl-3-(4-methylpiperazin-1-ylmethyl)-5-nitro-1 H-indole; 1-[[5-Bromo-1-(2-Bromo-4-methoxybenzenesulfonyl)-indo1-3-yl]methyl][1,4]diazepane; useful for treating psychotic and neurodegenerative disorders e.g. schizophrenia, Alzheimer's disease, Parkinson's disease and Huntington's chorea |
| 01/25/2011 | US7875600 To reducte the purinergic neurotransmission; Parkinson's disease; dyskinesias; Movement disorders; Adenosine receptors antagonists; 2-Methylamino-6-(5-methyl-2-furyl)-N-(2-pyridylmethyl)pyrimidine-4-carboxamide |
| 01/25/2011 | US7875467 Chemiluminescence; quantitative analysis of macromolecules; complexing sample to acridinium compound, labels for improving sensitivity of immunoassays, 2',6'-dimethyl-4'-N-succinimidyloxycaproyl-amidocarbonylphenyl-N10-2,7-tris[O-methoxyhexa(ethylene) glycol-sulfonamidylpropyl]-acridinium-9-carboxylate |
| 01/25/2011 | CA2612287C Substituted arylpyrazoles for use against parasites |
| 01/25/2011 | CA2552087C Methods for making 4-tetrazolyl-4-phenylpiperidine compounds |
| 01/25/2011 | CA2476983C Methods and compositions using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione for treatment and management of multiple myeloma |
| 01/25/2011 | CA2460180C Microbiocidal n-phenyl-n-[4-(4-pyridyl)-2-pyrimidin-2-yl]-amine derivatives |
| 01/25/2011 | CA2410345C Substituted pyridine herbicides |
| 01/25/2011 | CA2381882C Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases |
| 01/20/2011 | WO2011008809A1 Crystalline freebase forms of a biphenyl compound |
| 01/20/2011 | WO2011008709A1 Apoptosis signal-regulating kinase inhibitors |
| 01/20/2011 | WO2011008663A1 Gpr119 agonists |
| 01/20/2011 | WO2011007819A1 Pharmaceutical product containing lactam or benzene sulfonamide compound |
| 01/20/2011 | WO2011007145A1 Phthalazinone compound as parp inhibitor |
| 01/20/2011 | WO2011007091A1 Derivatives of 5,6-bisaryl-2-pyridine-carboxamide, preparation thereof, and therapeutic use thereof as urotensin-ii receptor antagonists |
| 01/20/2011 | WO2011006960A1 Spiro amino compounds suitable for the treatment of inter alia sleep disorders and drug addiction |
| 01/20/2011 | WO2011006910A1 Imidazole derivatives as mglur5 antagonists |
| 01/20/2011 | WO2011006903A1 Substituted triazole and imidazole derivatives as gamma secretase modulators |
| 01/20/2011 | WO2011006803A1 3-0x0-2, 3, -dihydro-lh-isoindole-4-carboxamides with selective parp-1 inhibition |
| 01/20/2011 | WO2011006794A1 3-oxo-2, 3-dihydro-lh-isoindole-4-carboxamides as parp inhibitors |
| 01/20/2011 | WO2011006567A1 Aminopyridine derivatives for treating tumors and inflammatory diseases |
| 01/20/2011 | WO2011006536A1 Pyridyl-substituted isoquinoline derivatives with activity againstmycobacteriaand especially myobacterium tuberculosis |
| 01/20/2011 | WO2010141331A3 Stereoselective synthesis of certain trifluoromethyl-substituted alcohols |
| 01/20/2011 | US20110015396 Tunable phenylacetylene hosts |
| 01/20/2011 | US20110015395 Pyrazole compounds with inhibitory activity against ros kinase |
| 01/20/2011 | US20110015393 Phthalazinone compound |
| 01/20/2011 | US20110015390 Process |
| 01/20/2011 | US20110015315 Process for the synthesis of n-alkoxyamines |
| 01/20/2011 | US20110015236 Fungicide hydroximoyl-tetrazole derivatives |
| 01/20/2011 | US20110015235 Novel phenylethynyl derivatives of 8-aza-bicyclo[3.2.1]octane and their use as monoamine neurotransmitter re-uptake inhibitors |
| 01/20/2011 | US20110015234 Indazole derivatives |
| 01/20/2011 | US20110015232 Pyrrolydine Derivatives as IAP Inhibitors |
| 01/20/2011 | US20110015228 Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione |
| 01/20/2011 | US20110015225 Heterocyclic compound |
| 01/20/2011 | US20110015215 Crystalline forms of 4-[6-(6-methanesulfonyl-2-methyl-pyridin-3-ylamino)-5-methoxy-pyrimidin-4-yloxy]-piperidine-1-carboxylic acid isopropyl ester |
| 01/20/2011 | US20110015206 Method of stabilizing lipid-rich plaque and method of preventing rupture thereof |
| 01/20/2011 | US20110015203 Viral Polymerase Inhibitors |
| 01/20/2011 | US20110015202 Imidazoles |
| 01/20/2011 | US20110015199 GPR119 Agonists |
| 01/20/2011 | US20110015198 Diarylmethylamide derivative having melanin-concentrating hormone receptor antagonism |
| 01/20/2011 | US20110015181 Alkylaminopyridine derivative |
| 01/20/2011 | US20110015180 Chemokine receptor antagonists |
| 01/20/2011 | US20110015171 Azetidinyl diamides as monoacylglycerol lipase inhibitors |
| 01/20/2011 | US20110015163 Crystalline freebase forms of a biphenyl compound |
| 01/20/2011 | US20110015156 Heterocyclic compounds for the treatment of neurological and psychological disorders |
| 01/20/2011 | US20110015152 Diarylmethyl and related compounds |
| 01/20/2011 | US20110015065 Substituted Sulfonic Acid Amide Compounds |
| 01/20/2011 | US20110014721 Hydrophilic chemiluminescent acridinium labeling reagents |
| 01/20/2011 | US20110014226 high throughput protein interaction assay |
| 01/20/2011 | US20110014121 Modulators of cxcr7 |
| 01/20/2011 | US20110012092 Nitrogen-containing heterocyclic derivative and organic electroluminescent device using the same |
| 01/20/2011 | US20110012075 Infrared absorptive compound, and fine particle containing the compound |
| 01/20/2011 | US20110011417 Dye composition containing a thiol/disulphide fluorescent dye comprising a heterocycle,and comprising an internal cationic charge, process for lightening keratin materials using this dye |
| 01/20/2011 | CA2778517A1 Substituted triazole and imidazole derivatives as gamma secretase modulators |
| 01/20/2011 | CA2768329A1 Spiro amino compounds suitable for the treatment of inter alia sleep disorders and drug addiction |
| 01/20/2011 | CA2768169A1 Aminopyridine derivatives for the treatment of tumors and inflammatory diseases |
| 01/20/2011 | CA2767894A1 Apoptosis signal-regulating kinase inhibitors |
| 01/20/2011 | CA2765921A1 Imidazole derivatives as mglur5 antagonists |
| 01/20/2011 | CA2765621A1 Crystalline freebase forms of a biphenyl compound |
| 01/20/2011 | CA2764906A1 Gpr119 agonists |
| 01/19/2011 | EP2275422A1 Pyrimidinylpyrazoles as insecticide and parasiticide agents |
| 01/19/2011 | EP2275421A1 Spiro amino compounds suitable for the treatment of inter alia sleep disorders and drug addiction |
| 01/19/2011 | EP2275420A1 Therapeutic agents useful for treating pain |
| 01/19/2011 | EP2275413A1 2,4-di(phenylamino)-pyrimidines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders. |
| 01/19/2011 | EP2275412A1 Indole and benzimidazole derivatives |
| 01/19/2011 | EP2275395A2 Copper-catalyzed formation of carbon-carbon bonds |
| 01/19/2011 | EP2275139A1 Oral pharmaceutical dosage forms comprising a proton pump inhibitor and a NSAID |
| 01/19/2011 | EP2275105A1 Heterocyclic derivatives as opioid receptor modulators |
| 01/19/2011 | EP2275102A1 N3 alkylated benzimidazole derivatives as MEK inhibitors |
| 01/19/2011 | EP2274304A1 Method of treating cancer using a cmet and axl inhibitor and an erbb inhibitor |
| 01/19/2011 | EP2274302A2 Compounds and compositions as itpkb inhibitors |
| 01/19/2011 | EP2274301A1 Aza-bicyclohexyl substituted indolyl alkyl amino derivatives as novel inhibitors of histone deacetylase |
| 01/19/2011 | EP2274300A2 Novel heterocyclic compounds and uses therof |
| 01/19/2011 | EP2274299A1 Heteroaryl-substituted dicyanopyridines and use thereof for treatment of cardiovascular diseases |
| 01/19/2011 | EP2274298A1 (5r)-1,5-diaryl-4,5-dihydro-1h-pyrazole-3-carboxamidine derivatives having cb1-antagonistic activity |
| 01/19/2011 | EP2274297A1 Pyrrolidinone glucokinase activators |
| 01/19/2011 | EP2274296A1 Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists |
| 01/19/2011 | EP2274295A1 3, 4 - substituted piperidine derivatives as renin inhibitors |
| 01/19/2011 | EP2274287A1 Inhibitors of 11beta-hydroxysteroid dehydrogenase type 1 |
| 01/19/2011 | EP2274283A1 Novel n-substituted tetrahydroisoquinoline/isoindoline hydroxamic acid compounds |
| 01/19/2011 | EP2274282A1 Compounds for use in stabilizing p53 mutants |
| 01/19/2011 | EP2273992A1 Quenolines and related analogs as sirtuin modulators |
| 01/19/2011 | EP2150546B1 Pyrimidine derivatives as inhibitors of phosphatidylinositol-3-kinase |
| 01/19/2011 | EP2094685B1 3-heteroaryl (amino or amido)-1- (biphenyl or phenylthiazolyl) carbonylpiperdine derivatives as orexin receptor inhibitors |
| 01/19/2011 | EP2035375B1 1,3-disubstituted 4-methyl-1h-pyrrole-2-carboxamides and their use for the manufacture of medicaments |
| 01/19/2011 | EP1922135B1 Hindered cyclic polyamines and their salts for acid gas scrubbing process |
| 01/19/2011 | EP1919899B1 Macrocyclic inhibitors of hepatitis c virus |
| 01/19/2011 | EP1902045B1 2,6 quinolinyl derivatives, processes for preparing them and their use as medicament |
| 01/19/2011 | EP1644336B1 Nitrogen-containing heteroaryl compounds and their use in increasing endogeneous erythropoietin |